Department of Pharmacology and Arizona Cancer Center, University of Arizona, Tucson, AZ, 85716, USA.
Eur J Neurosci. 2014 Feb;39(3):508-19. doi: 10.1111/ejn.12462.
Disorders of the skeleton are one of the most common causes of chronic pain and long-term physical disability in the world. Chronic skeletal pain is caused by a remarkably diverse group of conditions including trauma-induced fracture, osteoarthritis, osteoporosis, low back pain, orthopedic procedures, celiac disease, sickle cell disease and bone cancer. While these disorders are diverse, what they share in common is that when chronic skeletal pain occurs in these disorders, there are currently few therapies that can fully control the pain without significant unwanted side effects. In this review we focus on recent advances in our knowledge concerning the unique population of primary afferent sensory nerve fibers that innervate the skeleton, the nociceptive and neuropathic mechanisms that are involved in driving skeletal pain, and the neurochemical and structural changes that can occur in sensory and sympathetic nerve fibers and the CNS in chronic skeletal pain. We also discuss therapies targeting nerve growth factor or sclerostin for treating skeletal pain. These therapies have provided unique insight into the factors that drive skeletal pain and the structural decline that occurs in the aging skeleton. We conclude by discussing how these advances have changed our understanding and potentially the therapeutic options for treating and/or preventing chronic pain in the injured, diseased and aged skeleton.
骨骼疾病是世界上导致慢性疼痛和长期身体残疾的最常见原因之一。慢性骨骼疼痛由一组显著不同的疾病引起,包括创伤引起的骨折、骨关节炎、骨质疏松症、腰痛、骨科手术、乳糜泻、镰状细胞病和骨癌。虽然这些疾病多种多样,但它们的共同点是,当这些疾病发生慢性骨骼疼痛时,目前几乎没有可以完全控制疼痛而没有明显不良反应的治疗方法。在这篇综述中,我们重点介绍了有关支配骨骼的初级传入感觉神经纤维的独特群体、涉及驱动骨骼疼痛的伤害感受和神经病理性机制、以及在慢性骨骼疼痛中可能发生的感觉和交感神经纤维和中枢神经系统的神经化学和结构变化方面的最新进展。我们还讨论了针对神经生长因子或硬化蛋白治疗骨骼疼痛的治疗方法。这些治疗方法为驱动骨骼疼痛的因素以及衰老骨骼中发生的结构下降提供了独特的见解。最后,我们讨论了这些进展如何改变了我们对受伤、患病和衰老骨骼中慢性疼痛的治疗和/或预防的理解以及潜在的治疗选择。